Skip to main content
Log in

Clinical features of thyroid cancer in paediatric age. Experience of a tertiary centre in the 2000–2020 period

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

To describe the clinical features of a paediatric cohort affected by differentiated thyroid cancer (DTC) followed in a tertiary Department of Paediatric Endocrinology.

Methods

Clinical data of 41 patients affected by DTC in the 2000–2020 period were reviewed.

Results

The main risk factor was autoimmune thyroiditis (39%). Cytological categories were TIR3b in 39%, TIR4 in 9.8%, TIR5 in 51.2%. After total thyroidectomy, radioiodine treatment was performed in 38 subjects (92.7%). ATA low-risk category was assigned in 11 (30.5%), intermediate-risk category in 15 (41.7%), and high-risk category in 10 patients (27.8%). Age at diagnosis was 15.1 ± 0.92 years in low-risk category, 14.7 ± 0.59 in intermediate-risk category, 11.7 ± 0.89 years in high-risk category (p = 0.01). TIR3b was manly observed in low-risk class (63.6%), while TIR5 was mainly reported in intermediate and high-risk class (60 and 80% respectively) (p = 0.04). Post-surgery stimulated thyroglobulin was increased in high-risk class (407.8 ± 307.1 ng/ml) [p = 0.04]. Tumour size was larger in high-risk category (42.6 ± 2.6 mm), than in low and intermediate-risk categories (19.4 ± 3.5 mm and 28.5 ± 3.9 mm, respectively) (p = 0.008). Patients in intermediate and high-risk categories displayed more tumour multifocality (60 and 90% respectively) (p < 0.005). Disease relapse was mainly observed in high risk category (40%, p = 0.04).

Conclusion

DTC in childhood is more aggressive than in adults, but the overall survival rate is excellent. The therapeutic approach is still heterogeneous, especially in low-risk category. Further studies are needed to standardise management and reduce disease persistence in childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. Niedziela, Thyroid nodules. Best. Pr. Res Clin. Endocrinol. Metab. 28, 245–277 (2014). https://doi.org/10.1016/j.beem.2013.08.007

    Article  CAS  Google Scholar 

  2. J.L. Sandy, A. Titmuss, S. Hameed, Y.H. Cho, G. Sandler, P. Benitez-Aguirre, Thyroid nodules in children and adolescents: Investigation and management. J. Paediatr. Child Health 58, 2163–2168 (2022). https://doi.org/10.1111/jpc.16257

    Article  PubMed  PubMed Central  Google Scholar 

  3. M. Goldfarb, C. Dinauer, Differences in the management of thyroid nodules in children and adolescents as compared to adults. Curr. Opin. Endocrinol. Diabetes Obes. 29, 466–473 (2022). https://doi.org/10.1097/MED.0000000000000754

    Article  PubMed  Google Scholar 

  4. C.E. Cherella, T.E. Angell, D.M. Richman, M.C. Frates, C.B. Benson, F.D. Moore, J.A. Barletta, M. Hollowell, J.R. Smith, E.K. Alexander, E.S. Cibas, A.J. Wassner, Differences in thyroid nodule cytology and malignancy risk between children and adults. Thyroid 29, 1097–1104 (2019). https://doi.org/10.1089/thy.2018.0728

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. A. Corrias, A. Mussa, F. Baronio, T. Arrigo, M. Salerno, M. Segni, M.C. Vigone, R. Gastaldi, G. Zirilli, G. Tuli, L. Beccaria, L. Iughetti, S. Einaudi, G. Weber, F. De Luca, A. Cassio; Study Group for Thyroid Diseases of Italian Society for Pediatric Endocrinology and Diabetology (SIEDP/ISPED), Diagnostic features of thyroid nodules in pediatrics. Arch. Pediatr. Adolesc. Med 164, 714–719 (2010). https://doi.org/10.1001/archpediatrics.2010.114

    Article  PubMed  Google Scholar 

  6. A. Mussa, M.C. Salerno, G. Bona, M. Wasniewska, M. Segni, A. Cassio, M.C. Vigone, R. Gastaldi, L. Iughetti, A. Santanera, D. Capalbo, P. Matarazzo, F. De Luca, G. Weber, A. Corrias, Serum thyrotropin concentration in children with isolated thyroid nodules. J. Pediatr. 163, 1465–1470 (2013). https://doi.org/10.1016/j.jpeds.2013.07.003

    Article  CAS  PubMed  Google Scholar 

  7. R. Roy, G. Kouniavsky, E. Schneider, J.D. Allendorf, J.A. Chabot, P. Logerfo, A.P. Dackiw, P. Colombani, M.A. Zeiger, J.A. Lee, Predictive factors of malignancy in pediatric thyroid nodules. Surgery 150, 1228–1233 (2011). https://doi.org/10.1016/j.surg.2011.09.023

    Article  PubMed  Google Scholar 

  8. C.E. Cherella, H.A. Feldman, M. Hollowell, D.M. Richman, E.S. Cibas, J.R. Smith, T.E. Angell, Z. Wang, E.K. Alexander, A.J. Wassner, Natural history and outcomes of cytologically benign thyroid nodules in children. J. Clin. Endocrinol. Metab. 103, 3557–3565 (2018). https://doi.org/10.1210/jc.2018-00895

    Article  PubMed  PubMed Central  Google Scholar 

  9. G. Tuli, J. Munarin, E. Agosto, P. Matarazzo, F. Quaglino, A. Mormile, L. de Sanctis, Predictive factors of malignancy in pediatric patients with thyroid nodules and performance of the Italian classification (SIAPEC 2014) in the outcome of the cytological FNA categories. Endocrine 74, 365–374 (2021). https://doi.org/10.1007/s12020-021-02784-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. G. Keefe, K. Culbreath, C.E. Cherella, J.R. Smith, B. Zendejas, R.C. Shamberger, D.M. Richman, M.L. Hollowell, B.P. Modi, A.J. Wassner, Autoimmune thyroiditis and risk of malignancy in children with thyroid nodules. Thyroid 32, 1109–1117 (2022). https://doi.org/10.1089/thy.2022.0241

    Article  CAS  PubMed  Google Scholar 

  11. C.A. Lebbink, T.P. Links, A. Czarniecka, R.P. Dias, R. Elisei, L. Izatt, H. Krude, K. Lorenz, M. Luster, K. Newbold, A. Piccardo, M. Sobrinho-Simões, T. Takano, A.S. Paul van Trotsenburg, F.A. Verburg, H.M. van Santen, 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur. Thyroid J. 11, e220146 (2022). https://doi.org/10.1530/ETJ-22-0146

    Article  PubMed  PubMed Central  Google Scholar 

  12. G.L. Francis, S.G. Waguespack, A.J. Bauer, P. Angelos, S. Benvenga, J.M. Cerutti, C.A. Dinauer, J. Hamilton, I.D. Hay, M. Luster, M.T. Parisi, M. Rachmiel, G.B. Thompson, S. Yamashita; American Thyroid Association Guidelines Task Force, Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25, 716–759 (2015). https://doi.org/10.1089/thy.2014.0460

    Article  PubMed  PubMed Central  Google Scholar 

  13. A. Cozzolino, T. Filardi, I. Simonelli, G. Grani, C. Virili, I. Stramazzo, M.G. Santaguida, P. Locantore, M. Maurici, D. Gianfrilli, A.M. Isidori, C. Durante, C. Pozza, Diagnostic accuracy of ultrasonographic features in detecting thyroid cancer in the transition age: a meta-analysis. Eur. Thyroid J. 11, e220039 (2022). https://doi.org/10.1530/ETJ-22-0039

    Article  PubMed  PubMed Central  Google Scholar 

  14. G. Zirilli, L. Cannavò, F. Vermiglio, M.A. Violi, F. Luca, M. Wasniewska, Differentiated thyroid carcinoma presentation may be more aggressive in children and adolescents than in young adults. Ital. J. Pediatr. 44, 13 (2018). https://doi.org/10.1186/s13052-018-0455-3

    Article  PubMed  PubMed Central  Google Scholar 

  15. A.J. Bauer, Pediatric thyroid cancer: genetics, therapeutics and outcome. Endocrinol. Metab. Clin. North Am. 49, 589–611 (2020). https://doi.org/10.1016/j.ecl.2020.08.001

    Article  PubMed  Google Scholar 

  16. M.E. Nikita, W. Jiang, S.M. Cheng, F.M. Hantash, M.J. McPhaul, R.O. Newbury, S.A. Phillips, R.E. Reitz, F.M. Waldman, R.S. Newfield, Mutational analysis in pediatric thyroid cancer and correlations with age, ethnicity, and clinical presentation. Thyroid 26, 227–234 (2016). https://doi.org/10.1089/thy.2015.0401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. A.J. Bauer, Molecular genetics of thyroid cancer in children and adolescents. Endocrinol. Metab. Clin. North Am. 46, 389–403 (2017). https://doi.org/10.1016/j.ecl.2017.01.014

    Article  PubMed  Google Scholar 

  18. A.S. Remiker, J. Chuang, S. Corathers, M.M. Rutter, M.J. Rutter, C.M. Myer IV, M.J. Gelfand, A.T. Trout, J.I. Geller, Differentiated thyroid cancer in the pediatric/adolescent population: evolution of treatment. J. Pediatr. Hematol. Oncol. 41, 532–536 (2019). https://doi.org/10.1097/MPH.0000000000001493

    Article  CAS  PubMed  Google Scholar 

  19. A.B. Zanella, R.S. Scheffel, L. Weinert, J.M. Dora, A.L. Maia, New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review). Int J. Oncol. 58, 13 (2021). https://doi.org/10.3892/ijo.2021.5193

    Article  PubMed  Google Scholar 

  20. C.S. O’Gorman, J. Hamilton, M. Rachmiel, A. Gupta, B.Y. Ngan, D. Daneman, Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid 20, 375–380 (2010). https://doi.org/10.1089/thy.2009.0386

    Article  PubMed  Google Scholar 

  21. P. Papendieck, L. Gruñeiro-Papendieck, M. Venara, O. Acha, S. Maglio, I. Bergadá, A. Chiesa, Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents. J. Pediatr. Endocrinol. Metab. 24, 743–748 (2011). https://doi.org/10.1515/jpem.2011.241

    Article  PubMed  Google Scholar 

  22. L.B. Vergamini, A.L. Frazier, F.L. Abrantes, K.B. Ribeiro, C. Rodriguez-Galindo, Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. J. Pediatr. 164, 1481–1485 (2014). https://doi.org/10.1016/j.jpeds.2014.01.059

    Article  PubMed  Google Scholar 

  23. K. Sugino, M. Nagahama, W. Kitagawa, H. Shibuya, K. Ohkuwa, T. Uruno, A. Suzuki, J. Akaishi, C. Masaki, K. Matsuzu, K. Ito, Papillary thyroid carcinoma in children and adolescents: long-term follow-up and clinical characteristics. World J. Surg. 39, 2259–2265 (2015). https://doi.org/10.1007/s00268-015-3042-4

    Article  PubMed  Google Scholar 

  24. S. Golpanian, J. Tashiro, J.E. Sola, C. Allen, J.I. Lew, A.R. Hogan, H.L. Neville, E.A. Perez, Surgically treated pediatric nonpapillary thyroid carcinoma. Eur. J. Pediatr. Surg. 26, 524–532 (2016). https://doi.org/10.1055/s-0035-1569150

    Article  PubMed  Google Scholar 

  25. M.S. Klein Hesselink, M. Nies, G. Bocca, A.H. Brouwers, J.G. Burgerhof, E.W. van Dam, B. Havekes, M.M. van den Heuvel-Eibrink, E.P. Corssmit, L.C. Kremer, R.T. Netea-Maier, H.J. van der Pal, R.P. Peeters, K.W. Schmid, J.W. Smit, G.R. Williams, J.T. Plukker, C.M. Ronckers, H.M. van Santen, W.J. Tissing, T.P. Links, Pediatric differentiated thyroid carcinoma in the Netherlands: a nationwide follow-up study. J. Clin. Endocrinol. Metab. 101, 2031–2039 (2016). https://doi.org/10.1210/jc.2015-3290

    Article  CAS  PubMed  Google Scholar 

  26. I.D. Hay, T.R. Johnson, S. Kaggal, M.S. Reinalda, N.M. Iniguez-Ariza, C.S. Grant, S.T. Pittock, G.B. Thompson, Papillary thyroid carcinoma (PTC) in children and adults: comparison of initial presentation and long-term postoperative outcome in 4432 patients consecutively treated at the mayo clinic during eight decades (1936-2015). World J. Surg. 42, 329–342 (2018). https://doi.org/10.1007/s00268-017-4279-x

    Article  PubMed  Google Scholar 

  27. A. Zbitou, E. Desandes, S. Guissou, C. Mallebranche, B. Lacour, Thyroid cancers in children and adolescents in France: Incidence, survival and clinical management over the 2000-2018 period. Int J. Pediatr. Otorhinolaryngol. 162, 111325 (2022). https://doi.org/10.1016/j.ijporl.2022.111325

    Article  PubMed  Google Scholar 

  28. K.A. Lee, M.T.A. Sharabiani, D. Tumino, J. Wadsley, V. Gill, G. Gerrard, R. Sindhu, M.N. Gaze, L. Moss, K. Newbold, Differentiated thyroid cancer in children: a UK multicentre review and review of the literature. Clin. Oncol. 31, 385–390 (2019). https://doi.org/10.1016/j.clon.2019.02.005

    Article  CAS  Google Scholar 

  29. M. Negre Busó, A. García Burillo, M. Simó Perdigó, P. Galofré Mora, M. Boronat de Ferrater, G. Cuberas Borrós, C. Sábado Álvarez, J. Castell Conesa, Long-term follow-up of differentiated thyroid carcinoma in children and adolescents. J. Pediatr. Endocrinol. Metab. 33, 1431–1441 (2020). https://doi.org/10.1515/jpem-2020-0194

    Article  CAS  PubMed  Google Scholar 

  30. G.L. Banik, M.L. Shindo, K.L. Kraimer, K.L. Manzione, A. Reddy, K. Kazahaya, A.J. Bauer, J.C. Rastatter, M.E. Zafereo, S.G. Waguespack, D.C. Chelius Jr, L. Quintanilla-Dieck, Prevalence and risk factors for multifocality in pediatric thyroid cancer. JAMA Otolaryngol. Head. Neck Surg. 147, 1100–1106 (2021). https://doi.org/10.1001/jamaoto.2021.3077

    Article  PubMed  Google Scholar 

  31. C.E. Cherella, D.M. Richman, E. Liu, M.C. Frates, B.P. Modi, B. Zendejas, J.R. Smith, J.A. Barletta, M.L. Hollowell, A.J. Wassner, Predictors of bilateral disease in pediatric differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 106, 4242 (2021). https://doi.org/10.1210/clinem/dgab210

    Article  Google Scholar 

  32. C.S. Bal, A. Garg, S. Chopra, S. Ballal, R. Soundararajan, Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases. J. Pediatr. Endocrinol. Metab. 28, 745–751 (2015). https://doi.org/10.1515/jpem-2014-0247

    Article  PubMed  Google Scholar 

  33. K. Sugino, M. Nagahama, W. Kitagawa, K. Ohkuwa, T. Uruno, K. Matsuzu, A. Suzuki, C. Tomoda, K.Y. Hames, J. Akaishi, C. Masaki, K. Ito, Distant metastasis in pediatric and adolescent differentiated thyroid cancer: clinical outcomes and risk factor analyses. J. Clin. Endocrinol. Metab. 105, dgaa545 (2020). https://doi.org/10.1210/clinem/dgaa545

    Article  PubMed  Google Scholar 

  34. O. Karapanou, M. Tzanela, P. Rondogianni, C. Dacou-Voutetakis, D. Chiotis, B. Vlassopoulou, D. Vassiliadi, C. Kanaka-Gantenbein, S. Tsagarakis, Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence. Endocrine 70, 566–574 (2020). https://doi.org/10.1007/s12020-020-02378-2

    Article  CAS  PubMed  Google Scholar 

  35. A. Zanella, R.S. Scheffel, M.W. Pasa, J.M. Dora, A.L. Maia, Role of postoperative stimulated thyroglobulin as prognostic factor for differentiated thyroid cancer in children and adolescents. Thyroid 27, 787–792 (2017). https://doi.org/10.1089/thy.2016.0559

    Article  CAS  PubMed  Google Scholar 

  36. N.K. Jain, S. Mostoufi-Moab, C.P. Hawkes, N.D. Nelson, L.F. Surrey, Z.S. Jones, N.S. Adzick, K. Kazahaya, A.J. Bauer, Extrathyroidal extension is an important predictor of regional lymph node metastasis in pediatric differentiated thyroid cancer. Thyroid 30, 1037–1043 (2020). https://doi.org/10.1089/thy.2019.0229

    Article  CAS  PubMed  Google Scholar 

  37. E.J. Propst, J.D. Wasserman, J. Gorodensky, B.Y. Ngan, N.E. Wolter, Patterns and predictors of metastatic spread to the neck in pediatric thyroid carcinoma. Laryngoscope 131, 1002 (2021). https://doi.org/10.1002/lary.28937

    Article  Google Scholar 

  38. J.C. Rubinstein, K. Herrick-Reynolds, C. Dinauer, R. Morotti, D. Solomon, G.G. Callender, E.R. Christison-Lagay, Recurrence and complications in pediatric and adolescent papillary thyroid cancer in a high-volume practice. J. Surg. Res 249, 58–66 (2020). https://doi.org/10.1016/j.jss.2019.12.002

    Article  PubMed  Google Scholar 

  39. E. Christison-Lagay, R.M. Baertschiger, Management of differentiated thyroid carcinoma in pediatric patients. Surg. Oncol. Clin. N. Am. 30, 235–251 (2021). https://doi.org/10.1016/j.soc.2020.11.013

    Article  PubMed  Google Scholar 

  40. Y.A. Lee, H.W. Jung, H.Y. Kim, H. Choi, H.Y. Kim, J.H. Hah, D.J. Park, J.K. Chung, S.W. Yang, C.H. Shin, Y.J. Park, Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years. J. Clin. Endocrinol. Metab. 100, 1619–1629 (2015). https://doi.org/10.1210/jc.2014-3647

    Article  CAS  PubMed  Google Scholar 

  41. S.R. Howard, S. Freeston, B. Harrison, L. Izatt, S. Natu, K. Newbold, S. Pomplun, H.A. Spoudeas, S. Wilne, T.R. Kurzawinski, M.N. Gaze, Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline. Endocr. Relat. Cancer 29, 1 (2022). https://doi.org/10.1530/ERC-22-0035

    Article  Google Scholar 

  42. W.P. Kluijfhout, J.D. Pasternak, D. van der Kaay, M.R. Vriens, E.J. Propst, J.D. Wasserman, Is it time to reconsider lobectomy in low-risk paediatric thyroid cancer? Clin. Endocrinol. 86, 591–596 (2017). https://doi.org/10.1111/cen.13287

    Article  Google Scholar 

  43. C.K. Sudoko, C.M. Jenks, A.J. Bauer, A. Isaza, S. Mostoufi-Moab, L.F. Surrey, T.R. Bhatti, A. Franco, N.S. Adzick, K. Kazahaya, Thyroid lobectomy for T1 papillary thyroid carcinoma in pediatric patients. JAMA Otolaryngol. Head. Neck Surg. 147, 943–950 (2021). https://doi.org/10.1001/jamaoto.2021.2359

    Article  PubMed  Google Scholar 

  44. L. Lazar, Y. Lebenthal, K. Segal, A. Steinmetz, Y. Strenov, M. Cohen, I. Yaniv, M. Yackobovitch-Gavan, M. Phillip, Pediatric thyroid cancer: postoperative classifications and response to initial therapy as prognostic factors. J. Clin. Endocrinol. Metab. 101, 1970–1979 (2016). https://doi.org/10.1210/jc.2015-3960

    Article  CAS  PubMed  Google Scholar 

  45. G. Radetti, S. Loche, V. D’Antonio, M. Salerno, C. Guzzetti, T. Aversa, A. Cassio, M. Cappa, R. Gastaldi, F. Deluca, M.C. Vigone, G.M. Tronconi, A. Corrias, Influence of Hashimoto Thyroiditis on the development of thyroid nodules and cancer in children and adolescents. J. Endocr. Soc. 3, 607–616 (2019). https://doi.org/10.1210/js.2018-00287

    Article  PubMed  PubMed Central  Google Scholar 

  46. W.L. Ho, M.R. Zacharin, Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure. Eur. J. Pediatr. 175, 677–683 (2016). https://doi.org/10.1007/s00431-016-2692-z

    Article  CAS  PubMed  Google Scholar 

  47. C.A. Lebbink, S.G. Waguespack, H.M. van Santen, Thyroid dysfunction and thyroid cancer in childhood cancer survivors: prevalence, surveillance and management. Front. Horm. Res. 54, 140–153 (2021). https://doi.org/10.1159/000513805

    Article  CAS  PubMed  Google Scholar 

  48. H.M. van Santen, E.K. Alexander, S.A. Rivkees, E. Frey, S.C. Clement, M.P. Dierselhuis, C.A. Lebbink, T.P. Links, K. Lorenz, R.P. Peeters, C. Reiners, M.R. Vriens, P. Nathan, A.B. Schneider, F. Verburg, Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors. Eur. J. Endocrinol. 183, 1 (2020). https://doi.org/10.1530/EJE-20-0237

    Article  Google Scholar 

  49. S.C. Clement, C.A. Lebbink, M.S. Klein Hesselink, J.C. Teepen, T.P. Links, C.M. Ronckers, H.M. van Santen, Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study. Eur. J. Endocrinol. 183, 169–180 (2020). https://doi.org/10.1530/EJE-20-0153

    Article  CAS  PubMed  Google Scholar 

  50. W. Chemaitilly, C.A. Sklar, Childhood cancer treatments and associated endocrine late effects: a concise guide for the pediatric endocrinologist. Horm. Res Paediatr. 91, 74–82 (2019). https://doi.org/10.1159/000493943

    Article  CAS  PubMed  Google Scholar 

  51. J.D. Pole, A.M. Zuk, J.D. Wasserman, Diagnostic and treatment patterns among children, adolescents, and young adults with thyroid cancer in Ontario: 1992-2010. Thyroid 27, 1025–1033 (2017). https://doi.org/10.1089/thy.2016.0629

    Article  PubMed  Google Scholar 

  52. D. Albano, F. Bertagna, M.B. Panarotto, R. Giubbini Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Pediatr. Blood Cancer. 64 (2017). https://doi.org/10.1002/pbc.26595

  53. E. Pasqual, S. Schonfeld, L.M. Morton, D. Villoing, C. Lee, A. Berrington de Gonzalez, C.M. Kitahara, Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J. Clin. Oncol. 40, 1439–1449 (2022). https://doi.org/10.1200/JCO.21.01841

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study design and conception. Material preparation, data collection and analysis were performed by A.M., J.M. and G.T. The clinical management of the enroled subjects was managed by A.C., P.M., G.T., J.M., F.Q. and L.D. Sanctis. The first draft of the manuscript was written by G.T. and J.M. and all authors have commented on previous versions of the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Gerdi Tuli.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Consent to publish

Consent to publish has been received from all partecipants.

Consent to partecipate

Written parental consent was obtained.

Ethics approval

This study was conducted in line with the principles of the Declaration of Helsinki. The approval was granted by the Ethics Committee of the City of Health and Science University Hospital of Turin (01/10/2021, 13942/A1).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuli, G., Munarin, J., Matarazzo, P. et al. Clinical features of thyroid cancer in paediatric age. Experience of a tertiary centre in the 2000–2020 period. Endocrine 81, 322–329 (2023). https://doi.org/10.1007/s12020-023-03366-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03366-y

Keywords

Navigation